Tourmaline Bio Inc (TRML)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TRML | KALV | COLL | ||
| Company | Tourmaline Bio Inc | Kalvista Pharmaceuticals Inc | Collegium Pharma | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 47.98 | 26.66 | 33.79 | ||
| High | 48.00 | 26.69 | 34.35 | ||
| Low | 47.98 | 26.64 | 33.38 | ||
| Latest | 47.98 | 26.65 | 34.32 | ||
| Change | unch | -0.01 | +0.59 | ||
| % Change | unch | -0.04% | +1.75% | ||
| Volume | 783,700 | 5,120,800 | 344,400 | ||
| 20-Day Average Volume | 653,225 | 5,411,970 | 478,285 | ||
| Previous Close | 47.98 | 26.66 | 33.73 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 47.90 | 20.83 | 33.80 | ||
| 20-Day Raw Stochastic | 92.00% | 98.64% | 58.77% | ||
| 20-Day Relative Strength | 88.61 | 71.97 | 46.24 | ||
| Weighted Alpha | +50.87 | +89.86 | +8.25 | ||
| Today's Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 10/20/25 | +35.76% since 04/24/26 | +5.60% since 04/24/26 | ||
| Low | 47.90 on 10/21/25 | 18.94 on 04/27/26 | 32.40 on 04/29/26 | ||
| High | 48.00 on 10/27/25 | 26.76 on 04/29/26 | 34.35 on 05/01/26 | ||
| 1-Month | |||||
| %Chg | +0.50% since 09/26/25 | +34.80% since 04/01/26 | +3.22% since 04/01/26 | ||
| Low | 47.75 on 09/30/25 | 18.66 on 04/24/26 | 31.54 on 04/06/26 | ||
| High | 48.27 on 09/29/25 | 26.76 on 04/29/26 | 36.27 on 04/14/26 | ||
| 3-Month | |||||
| %Chg | +142.69% since 07/25/25 | +70.72% since 01/30/26 | -25.26% since 01/30/26 | ||
| Low | 19.75 on 08/08/25 | 14.23 on 02/17/26 | 31.54 on 04/06/26 | ||
| High | 48.27 on 09/29/25 | 26.76 on 04/29/26 | 49.31 on 02/05/26 | ||
| 6-Month | |||||
| %Chg | +184.07% since 04/25/25 | +144.27% since 10/31/25 | -4.67% since 10/31/25 | ||
| Low | 13.27 on 05/20/25 | 10.41 on 11/07/25 | 31.54 on 04/06/26 | ||
| High | 48.27 on 09/29/25 | 26.76 on 04/29/26 | 50.79 on 12/29/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,232,702 | 1,365,066 | 1,112,208 | ||
| Shares Outstanding, K | 25,692 | 51,222 | 32,407 | ||
| Annual Sales | 0 | 49,080,000 | 780,570,000 | ||
| Annual Net Income | -73,210,000 | -109,520,000 | 62,870,000 | ||
| Last Quarter Sales | 0 | 13,690,000 | 205,450,000 | ||
| Last Quarter Net Income | -23,090,000 | -49,480,000 | 16,960,000 | ||
| 60-Month Beta | 2.27 | -0.12 | 0.76 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.90 on 08/13/25 | -0.92 on 11/10/25 | 2.04 on 02/26/26 | ||
| Earnings Date | 11/06/25 | 03/24/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 5.10 | ||